Disturbances of the transfer of cholesterol to high-density lipoprotein (HDL) in patients with peripheral artery disease with or without type 2 diabetes mellitus.
cholesteryl ester transfer protein (CETP)
diabetes
dyslipidemia
high-density lipoprotein (HDL)
lipid nanoparticles
peripheral artery disease (PAD)
unesterified cholesterol
Journal
Vascular medicine (London, England)
ISSN: 1477-0377
Titre abrégé: Vasc Med
Pays: England
ID NLM: 9610930
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
pubmed:
18
6
2021
medline:
11
3
2022
entrez:
17
6
2021
Statut:
ppublish
Résumé
Low high-density lipoprotein (HDL)-cholesterol is frequent in patients with peripheral artery disease (PAD) and also in type 2 diabetes mellitus (T2DM), the major risk factor for PAD. The transfer of cholesterol from the other lipoproteins to HDL is an important aspect of HDL metabolism and function, and may contribute to atherogenic mechanisms that lead to PAD development. The aim of this study was to investigate the status of cholesterol transfers in patients with PAD without or with T2DM. Patients with PAD ( Low-density lipoprotein (LDL)-cholesterol and triglycerides were similar in the three groups. Compared to controls, HDL-C was lower in PAD + DM ( Deficient cholesterol transfer to HDL may play a role in PAD pathogenesis. Since UC transfer to HDL was lower in PAD + DM compared to PAD alone, it is possible that defective HDL metabolism may contribute to the higher PAD incidence in patients with T2DM.Keywords.
Identifiants
pubmed: 34137646
doi: 10.1177/1358863X211021142
doi:
Substances chimiques
Cholesterol, HDL
0
Lipoproteins, HDL
0
Cholesterol
97C5T2UQ7J
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM